Ted W. Love - Feb 1, 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc. (GBT)

Role
President and CEO, Director
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Stock symbol
GBT
Transactions as of
Feb 1, 2022
Transactions value $
-$308,874
Form type
4
Date filed
2/3/2022, 04:47 PM
Previous filing
Sep 3, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Options Exercise +30K +3.89% 799K Feb 1, 2022 Direct F1, F2
transaction GBT Common Stock Tax liability -$309K -10.5K -1.32% $29.33 789K Feb 1, 2022 Direct F2, F3
holding GBT Common Stock 102K Feb 1, 2022 By Trust 1
holding GBT Common Stock 102K Feb 1, 2022 By Trust 2
holding GBT Common Stock 102K Feb 1, 2022 By Trust 3
holding GBT Common Stock 2.5K Feb 1, 2022 By Daughter
holding GBT Common Stock 2.5K Feb 1, 2022 By Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Restricted Stock Units Options Exercise $0 -9.75K -100% $0.00* 0 Feb 1, 2022 Common Stock 9.75K Direct F1, F4
transaction GBT Restricted Stock Units Options Exercise $0 -11.3K -33.33% $0.00 22.5K Feb 1, 2022 Common Stock 11.3K Direct F1, F5
transaction GBT Restricted Stock Units Options Exercise $0 -8.96K -20% $0.00 35.8K Feb 1, 2022 Common Stock 8.96K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Corrected balance; see Form 4/A filed on January 6, 2022.
F3 Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 29,955 shares of Common Stock underlying the Reporting Person's RSUs.
F4 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
F5 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
F6 The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.